429 related articles for article (PubMed ID: 27908752)
1. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
[TBL] [Abstract][Full Text] [Related]
2. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents.
Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S
Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents.
Ye C; Xu R; Cao Z; Song Q; Yu G; Shi Y; Liu Z; Liu X; Deng Y
Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease.
Wang K; Shi J; Zhou Y; He Y; Mi J; Yang J; Liu S; Tang X; Liu W; Tan Z; Sang Z
Bioorg Chem; 2021 Jul; 112():104879. PubMed ID: 33915461
[TBL] [Abstract][Full Text] [Related]
8. Scouting around 1,2,3,4-Tetrahydrochromeno[3,2-c]pyridin-10-ones for Single- and Multitarget Ligands Directed towards Relevant Alzheimer's Targets.
Purgatorio R; Kulikova LN; Pisani L; Catto M; de Candia M; Carrieri A; Cellamare S; De Palma A; Beloglazkin AA; Reza Raesi G; Voskressensky LG; Altomare CD
ChemMedChem; 2020 Oct; 15(20):1947-1955. PubMed ID: 32716595
[TBL] [Abstract][Full Text] [Related]
9. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation.
Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L
Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Xu YX; Wang H; Li XK; Dong SN; Liu WW; Gong Q; Wang TD; Tang Y; Zhu J; Li J; Zhang HY; Mao F
Eur J Med Chem; 2018 Jan; 143():33-47. PubMed ID: 29172081
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease.
Xie SS; Liu J; Tang C; Pang C; Li Q; Qin Y; Nong X; Zhang Z; Guo J; Cheng M; Tang W; Liang N; Jiang N
Eur J Med Chem; 2020 Sep; 202():112475. PubMed ID: 32652406
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities.
Takao K; Toda K; Saito T; Sugita Y
Chem Pharm Bull (Tokyo); 2017; 65(11):1020-1027. PubMed ID: 29093288
[TBL] [Abstract][Full Text] [Related]
15. Cyanobiphenyls: Novel H
Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
[TBL] [Abstract][Full Text] [Related]
16. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ
Plazas E; Hagenow S; Avila Murillo M; Stark H; Cuca LE
Bioorg Chem; 2020 May; 98():103722. PubMed ID: 32155491
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Zhang P; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Oct; 180():238-252. PubMed ID: 31310916
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
[TBL] [Abstract][Full Text] [Related]
19. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
